Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: gbull who wrote (9627)	7/2/1998 6:33:00 PM
From: dowman	Read Replies (3) \| Respond to of 14328

I say again, call the CDC and ask for the often quoted people on this board . You will find the following. Currently the FDA is holding up all applications that do not have a valid license for HIV2. ( I believe currently this pertains only to TRIBY, but most likely others who will not submit knowing the current FDA stance) As I have said, some individuals at the CDC are lobbying the FDA to change this position, consistent with the article on this board back in March about rapid testing. If the FDA does not change their current stance this will be a problem for Triby, because they do no have a license to use a test claiming to detect HIV2 as this patent is held by Sanofi. You will notice the reference to Genetic Systems and HIV2 in that article. They are a division of Sanofi, and thus licensed. Call them and ask about this issue.There is no one who has refuted anything I have posted with any facts, but plenty of bluster. The CDC sight is meaningful only as an indication of their stance, which I have consistently stated in previous posts. It is in fact I who have done the research and you who refuse to make the call. Yes I have sources, and I worked hard for them and not likely to give them away to the sis boom bah gang on this board. There was nothing in the CDC sight about HIV2 that refutes anything I said.